Oral Contraceptive Users Have Lower Prevalence of Depression
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 5, 2023 -- Women using the oral contraceptive pill (OCP) have reduced prevalence of major depression, according to a study scheduled to be published in the Jan. 1, 2024, issue of the Journal of Affective Disorders.
Julia Gawronska, Ph.D., from Anglia Ruskin University in Cambridge, England, and colleagues used the National Health and Nutrition Examination Survey 2005 to 2012 data to examine the prevalence and correlates of depression in women using OCP. The analysis included 6,239 women aged 18 to 55 years.
The researchers found that compared with former and never users of OCP, current OCP users had lower prevalence of major depression (4.6 percent versus 11.4 and 10.0 percent, respectively). After adjustment for potential confounders, current OCP users were significantly less likely to report major depression than former OCP users (odd ratio, 0.59). In women who were Black or Hispanic, women who were widowed/divorced/separated, those with a low or middle income, current smokers, current users of antidepressants, and those with history of cancer or thyroid problems, the prevalence of major depression was higher.
"In this large sample of U.S. women, we found that women using OCP are less likely to experience clinically relevant major depression compared to women who previously used OCP," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Child Maltreatment Linked to Externalizing, Internalizing Behavior
TUESDAY, May 14, 2024 -- Child maltreatment is associated with increases in externalizing and internalizing behaviors, according to a study published online May 14 in...
Virtual Reality Therapy Can Augment Depression Treatment
MONDAY, May 13, 2024 -- Extended reality-enhanced behavioral activation (XR-BA) may be a feasible, noninferior, and acceptable enhancement to traditional BA for major depressive...
Risk for Depressive Symptoms Increased for Perimenopausal Women
THURSDAY, May 9, 2024 -- Perimenopausal women have an increased risk for depressive symptoms and diagnoses, according to a review published in the July 15 issue of the Journal of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.